$AVBP
ArriVent BioPharma, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Newtown Square, PA
AVBP chart
What traders are saying about $AVBP
Latest postsArriVent BioPharma, Inc. news
- Truist raises ArriVent BioPharma stock price target on drug data
Investing.com ·
- Guggenheim maintains Buy rating on ArriVent BioPharma, $30 price target
TradingView ·
- ArriVent Lung Cancer Drug Shows 68% Response Rate in Trial
MyChesCo ·
- Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Oric Pharmaceuticals (ORIC)
The Globe and Mail ·
- ArriVent BioPharma’s ARR-217 Shows 44.8% Response Rate in Colorectal Cancer Study
marketbeat.com ·
- ArriVent BioPharma (AVBP) Advances ARR 217 Into Phase 1b, Is The Selloff Overdone?
Yahoo Finance ·
- ArriVent BioPharma, Inc. Stock 12‑Month Price Target Raised to $24, Implies 14% Upside
TradingView ·
- 12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga ·
- (AVBP) Price Dynamics and Execution-Aware Positioning
Stock Traders Daily ·
- ArriVent Biopharma announces initial Phase 1 results for ARR-217
TipRanks ·
- AVBP: ARR-217 yielded 44.8% ORR at 6 mg/kg Q3W in pretreated CRC; Phase 1b is underway
TradingView ·
- Form 8K Arrivent Biopharma Inc For: 26 October By Investing.com
Investing.com Nigeria ·
ArriVent BioPharma, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$166.3M | -$80.5M | -$69.3M |
| Diluted EPS | $-4.32 | $-2.56 | $-32.38 |
| Total assets (year end) | $333.2M | $274.9M | $163.1M |
| Cash and equivalents (year end) | $45.5M | $74.3M | $150.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About ArriVent BioPharma, Inc.
- Ticker
- AVBP (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Newtown Square, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1868279
Frequently asked questions
What exchange is ArriVent BioPharma, Inc. listed on?
ArriVent BioPharma, Inc. trades on the Nasdaq under the ticker symbol AVBP.
What industry is ArriVent BioPharma, Inc. in?
ArriVent BioPharma, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is ArriVent BioPharma, Inc. headquartered?
ArriVent BioPharma, Inc.'s business address on file with the SEC is in Newtown Square, PA.
When does ArriVent BioPharma, Inc.'s fiscal year end?
ArriVent BioPharma, Inc.'s fiscal year ends on December 31.